MIRM 241220 12.50P (MIRM241220P12500) Stock Options, News & Quotes

US OptionsDetailed Quotes

MIRM241220P12500

Watchlist

0.00
0.000.00%

15min DelayTrading Dec 3 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Would Mirum Pharmaceuticals (NASDAQ:MIRM) Be Better Off With Less Debt?
Simply Wall St06:20 ET
Mirum Shares Surge More Than 90% in 6 Months: Here's Why
Zacks Nov 29 09:05 ET
Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Mirum Pharmaceuticals (MIRM)
TipRanksNov 21 07:11 ET · Ratings
Express News | Mirum Pharmaceuticals Inc : JP Morgan Raises Target Price to $54 From $39
ReutersNov 19 05:28 ET
Analysts Are Updating Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates After Its Third-Quarter Results
Yahoo FinanceNov 15 08:20 ET
Evercore Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $68
Moomoo NewsNov 14 08:35 ET · Ratings

Comments

TrendTrader

Jul 26 14:17

Looking for 45, 47 and 50

$Mirum Pharmaceuticals (MIRM.US)$

Mark Livermore

Jul 7 23:26

Watchlist

$Mirum Pharmaceuticals (MIRM.US)$
PROS-IPO on Jul 2019; triple digit on recent quarterly sales; ADR6.4%; dollar average volume>10MM; interesting volume; ATH; RS rating=89; near time high.
CONS-might need to wait for 10MA to catch up.
$iLearningEngines (AILE.US)$
PROS-IPO on Apr 2024 after business combination; AI theme; ADR12.33%; price increased approximately 90% in 1 month and sideway consolidate, building higher low and surphing 10 MA; vol drying up.
CONS-dollar volume between 1MM to 5...

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Meltyy

Mar 11 22:36

4 PDUFA decisions this week!

Last week’s PDUFAs:
$BeiGene (BGNE.US)$ : Approved 3/8 🎉
⇒ BRUKINSA + obinutuzumab
⇒ Follicular Lymphoma
⇒ sNDA
⇒ PDUFA date: Mar 2024
$Bristol-Myers Squibb (BMY.US)$ : Approved 3/8 🎉
⇒ Opdivo ® + Cisplatin & Gemcitabine
⇒ Urothelial carcinoma
⇒ sBLA
⇒ PDUFA: 04/05/24
$Vanda Pharmaceuticals (VNDA.US)$ : CRL 3/4 🙁
⇒ HETLIOZ®
⇒ insomnia
⇒ sNDA
⇒ PDUFA: 03/04/24
$Eyenovia (EYEN.US)$ : Approved 3/4 🎉
⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
⇒ postop eye pa...

Meltyy

Feb 27 21:34

FDA Calendar-March

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Eyenovia (EYEN.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $Mirum Pharmaceuticals (MIRM.US)$ $Madrigal Pharmaceuticals (MDGL.US)$ $Geron (GERN.US)$ $Bristol-Myers Squibb (BMY.US)$ $2seventy bio (TSVT.US)$ $Legend Biotech (LEGN.US)$ $OptiNose (OPTN.US)$ $Orchard Therapeutics (ORTX.US)$ $Merck & Co (MRK.US)$ $Akebia Therapeutics (AKBA.US)$ $AstraZeneca (AZN.US)$ $Liquidia (LQDA.US)$ $Esperion Therapeutics (ESPR.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $BeiGene (BGNE.US)$